IL122338A0 - Methods of inhibiting phagocytosis - Google Patents
Methods of inhibiting phagocytosisInfo
- Publication number
- IL122338A0 IL122338A0 IL12233896A IL12233896A IL122338A0 IL 122338 A0 IL122338 A0 IL 122338A0 IL 12233896 A IL12233896 A IL 12233896A IL 12233896 A IL12233896 A IL 12233896A IL 122338 A0 IL122338 A0 IL 122338A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- inhibiting phagocytosis
- phagocytosis
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48353095A | 1995-06-07 | 1995-06-07 | |
PCT/US1996/010494 WO1996040199A1 (en) | 1995-06-07 | 1996-06-07 | Methods of inhibiting phagocytosis |
Publications (1)
Publication Number | Publication Date |
---|---|
IL122338A0 true IL122338A0 (en) | 1998-04-05 |
Family
ID=23920431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12233896A IL122338A0 (en) | 1995-06-07 | 1996-06-07 | Methods of inhibiting phagocytosis |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0831875A4 (en) |
JP (1) | JPH11507824A (en) |
AU (1) | AU723595B2 (en) |
CA (1) | CA2223402C (en) |
IL (1) | IL122338A0 (en) |
WO (1) | WO1996040199A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
GB9822763D0 (en) * | 1998-10-20 | 1998-12-16 | Univ Sheffield | Immunoglobin variant |
EP1006183A1 (en) * | 1998-12-03 | 2000-06-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Recombinant soluble Fc receptors |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
WO2002089832A2 (en) * | 2001-05-09 | 2002-11-14 | Alk-Abelló A/S | Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
WO2005049838A2 (en) | 2003-11-14 | 2005-06-02 | Yale University | Syk-targeted nucleic acid interference |
TW200808360A (en) | 2006-04-13 | 2008-02-16 | Alcon Mfg Ltd | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions |
GB201509413D0 (en) * | 2015-06-01 | 2015-07-15 | Ucl Business Plc | Fusion protein |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL111105A (en) * | 1993-09-30 | 2009-05-04 | Univ Pennsylvania | Use of a molecule capable of inhibiting the expression of syk kinase to prepare a pharmaceutical composition for inhibiting phagocytosis |
US5641863A (en) * | 1993-09-30 | 1997-06-24 | University Of Pennsylvania | Chimeric IgG Fc receptors |
WO1995014790A1 (en) * | 1993-11-23 | 1995-06-01 | Ciba Corning Diagnostics Corp. | Use of antisense oligomers in a process for controlling contamination in nucleic acid amplification reactions |
-
1996
- 1996-06-07 WO PCT/US1996/010494 patent/WO1996040199A1/en active Application Filing
- 1996-06-07 CA CA2223402A patent/CA2223402C/en not_active Expired - Fee Related
- 1996-06-07 EP EP96923327A patent/EP0831875A4/en not_active Ceased
- 1996-06-07 JP JP9502301A patent/JPH11507824A/en active Pending
- 1996-06-07 IL IL12233896A patent/IL122338A0/en unknown
- 1996-06-07 AU AU63869/96A patent/AU723595B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JPH11507824A (en) | 1999-07-13 |
EP0831875A4 (en) | 2002-07-31 |
WO1996040199A1 (en) | 1996-12-19 |
AU6386996A (en) | 1996-12-30 |
CA2223402C (en) | 2012-07-31 |
EP0831875A1 (en) | 1998-04-01 |
AU723595B2 (en) | 2000-08-31 |
CA2223402A1 (en) | 1996-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL322277A1 (en) | Derivatives of pyrazol-4-ylobenzoyl | |
PL327569A1 (en) | Promedications of thrombosin inhibitors | |
PL324451A1 (en) | Derivatives of diphenylmethylenepiperidine | |
PL327067A1 (en) | Method of obtaining pure melamine | |
PL323236A1 (en) | Method of obtaining lerkanipidin chlorchydride | |
IL116924A (en) | Preparation of n-aryl - and n-hetarylhydroxylamines | |
GB9624854D0 (en) | Structural part of hf-tight housings | |
IL122338A0 (en) | Methods of inhibiting phagocytosis | |
IL123320A0 (en) | Detection of hypoprathyroidism | |
IL118574A0 (en) | Methods of inhibiting melanoma | |
PL320114A1 (en) | Phenyl-substituted fluoroderivatives of 4-azasteroides | |
PL327147A1 (en) | Method of obtaining dihydropyrimidinones | |
PL326080A1 (en) | Short forms of chemokin beta-8 | |
ZA969429B (en) | Amidinohydrazones of ketones | |
IL117036A0 (en) | Methods of inhibiting effects of il-6 | |
PL326978A1 (en) | Method of obtaining dioxyaza bicyclohexanes | |
PL323148A1 (en) | Esters of crabapenemes | |
IL117786A (en) | Preparation of alpha-bisoximes | |
EG20782A (en) | Process of preparation streptogramines | |
PL312826A1 (en) | Method of obtaining dilthiazeme | |
SG64924A1 (en) | Inhibiting photodecompostion of 3-substituted-2- oxindoles | |
PL323141A1 (en) | Esters of crabapenemes | |
IL117365A0 (en) | Treatment of eczema | |
GB9504913D0 (en) | Production of trialkoxypropane | |
ZA962440B (en) | Destressing of railtracks |